FI820466L - Nytt seskvihydrat av naftyridinderivat och foerfarande foer des framstaellning - Google Patents

Nytt seskvihydrat av naftyridinderivat och foerfarande foer des framstaellning

Info

Publication number
FI820466L
FI820466L FI820466A FI820466A FI820466L FI 820466 L FI820466 L FI 820466L FI 820466 A FI820466 A FI 820466A FI 820466 A FI820466 A FI 820466A FI 820466 L FI820466 L FI 820466L
Authority
FI
Finland
Prior art keywords
seskvihydrat
naftyridinderivat
nytt
framstaellning
des
Prior art date
Application number
FI820466A
Other languages
English (en)
Other versions
FI71144B (fi
FI71144C (fi
Inventor
Hitoshi Ichihashi
Terukazu Tanaka
Yu Imasato
Original Assignee
Dainippon Pharmaceutical Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dainippon Pharmaceutical Co filed Critical Dainippon Pharmaceutical Co
Publication of FI820466L publication Critical patent/FI820466L/fi
Publication of FI71144B publication Critical patent/FI71144B/fi
Application granted granted Critical
Publication of FI71144C publication Critical patent/FI71144C/fi

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72Nitrogen atoms
    • C07D213/73Unsubstituted amino or imino radicals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72Nitrogen atoms
    • C07D213/74Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72Nitrogen atoms
    • C07D213/75Amino or imino radicals, acylated by carboxylic or carbonic acids, or by sulfur or nitrogen analogues thereof, e.g. carbamates
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72Nitrogen atoms
    • C07D213/76Nitrogen atoms to which a second hetero atom is attached
    • C07D213/77Hydrazine radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
FI820466A 1981-02-13 1982-02-12 Foerfarande foer framstaellning av terapeutiskt aktiv 1-etyl-6-fluor-1,4-dihydro-4-oxo-(1-piperazinyl)-1,8-naftyridin-3-karboxylsyraseskvihydrat FI71144C (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2074981 1981-02-13
JP56020749A JPS57134482A (en) 1981-02-13 1981-02-13 1-ethyl-6-fluoro-1,4-dihydro-4-oxo-7-(1-piperazinyl)-1,8- naphthyridine-3-carboxylic acid-3/2 hydrate and its preparation

Publications (3)

Publication Number Publication Date
FI820466L true FI820466L (fi) 1982-08-14
FI71144B FI71144B (fi) 1986-08-14
FI71144C FI71144C (fi) 1986-11-24

Family

ID=12035831

Family Applications (1)

Application Number Title Priority Date Filing Date
FI820466A FI71144C (fi) 1981-02-13 1982-02-12 Foerfarande foer framstaellning av terapeutiskt aktiv 1-etyl-6-fluor-1,4-dihydro-4-oxo-(1-piperazinyl)-1,8-naftyridin-3-karboxylsyraseskvihydrat

Country Status (19)

Country Link
US (1) US4442101A (fi)
EP (1) EP0058614B1 (fi)
JP (1) JPS57134482A (fi)
KR (1) KR870000322B1 (fi)
AU (1) AU547082B2 (fi)
CA (1) CA1216292A (fi)
CS (1) CS254958B2 (fi)
DD (1) DD202573A5 (fi)
DE (1) DE3266261D1 (fi)
DK (1) DK160046C (fi)
ES (1) ES8307793A1 (fi)
FI (1) FI71144C (fi)
HU (1) HU186473B (fi)
MX (1) MX158194A (fi)
NO (1) NO156721C (fi)
PH (1) PH18177A (fi)
PL (1) PL137259B1 (fi)
YU (1) YU43785B (fi)
ZA (1) ZA82740B (fi)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2758259A (en) * 1953-06-23 1956-08-07 Mallory & Co Inc P R Electrolytic capacitor device
US2856570A (en) * 1954-06-02 1958-10-14 Mallory & Co Inc P R Electrolytic capacitor
JPS57134482A (en) * 1981-02-13 1982-08-19 Dainippon Pharmaceut Co Ltd 1-ethyl-6-fluoro-1,4-dihydro-4-oxo-7-(1-piperazinyl)-1,8- naphthyridine-3-carboxylic acid-3/2 hydrate and its preparation
DE3308908A1 (de) * 1983-03-12 1984-09-13 Bayer Ag, 5090 Leverkusen Bakterizide mittel
US4639458A (en) * 1985-01-22 1987-01-27 Merck & Co., Inc. Tablet and formulation
HUT40429A (en) * 1985-04-29 1986-12-28 Chinoin Gyogyszer Es Vegyeszet Process for production of salts of derivatives of kynolin carbonic acid
US5422350A (en) * 1992-09-10 1995-06-06 Warner-Lambert Company Nitrogen substituted acridine and cytochrome P450 inhibitors and methods of use
US5466696A (en) * 1992-09-10 1995-11-14 Warner Lambert Company Tacrine and cytochrome P450 oxidase inhibitors and methods of use
JP3449658B2 (ja) * 1994-12-21 2003-09-22 杏林製薬株式会社 安定性に優れた8−アルコキシキノロンカルボン酸水和物並びにその製造方法
GB9820405D0 (en) * 1998-09-18 1998-11-11 Smithkline Beecham Plc Process
GB9920919D0 (en) 1999-09-03 1999-11-10 Sb Pharmco Inc Novel compound
GB9920917D0 (en) 1999-09-03 1999-11-10 Sb Pharmco Inc Novel process
KR100517638B1 (ko) 2002-04-08 2005-09-28 주식회사 엘지생명과학 게미플록사신 산염의 새로운 제조방법
US7842791B2 (en) * 2002-12-19 2010-11-30 Nancy Jean Britten Dispersible pharmaceutical compositions
JP2013510097A (ja) * 2009-11-03 2013-03-21 リウ、リー タンシノンiiaスルホン酸ナトリウム水和物、並びにその調製方法及び使用
US20160046603A1 (en) * 2013-03-08 2016-02-18 Melinta Therapeutics, Inc. Crystalline Forms of D-Glucitol, 1-Deoxy-1-(Methylamino)-, 1-(6-Amino-3,5-Difluoropyridine-2-Yl)-8-Chloro-6-Fluoro-1,4-Dihydro-7-(3-Hydroxyazetidin-1-Yl)-4-Oxo-3-Quinolinecarboxylate
KR102214067B1 (ko) 2014-02-27 2021-02-09 엘지전자 주식회사 산 질화물 형광체, 그 제조 방법 및 이를 이용한 발광 소자 패키지

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3149104A (en) * 1961-01-03 1964-09-15 Sterling Drug Inc 4-hydroxy-7-styryl-1, 8-naphthyridine-3-carboxylic acids and esters
US3590036A (en) * 1968-11-18 1971-06-29 George Y Lesher Naphthyridine-3-carboxylic acids,their derivatives and preparation thereof
DE2103805C3 (de) * 1970-01-28 1980-03-20 Sumitomo Chemical Co., Ltd., Osaka (Japan) Verfahren zur Herstellung von N-substituierten 6,7-Methylendioxy-4chinolonen
US4017622A (en) * 1972-12-18 1977-04-12 Dainippon Pharmaceutical Co., Ltd. Piperazine derivatives
JPS53141286A (en) * 1977-05-16 1978-12-08 Kyorin Seiyaku Kk Novel substituted quinolinecarboxylic acid
AR223983A1 (es) * 1978-08-25 1981-10-15 Dainippon Pharmaceutical Co Un procedimiento para-preparar derivados de acido 6-halogeno-4-oxo-7-(1-piperazinil)-1,8-naftiridin-3-carboxilico
JPS5845426B2 (ja) * 1978-09-29 1983-10-08 杏林製薬株式会社 置換キノリンカルボン酸誘導体
JPS57134482A (en) * 1981-02-13 1982-08-19 Dainippon Pharmaceut Co Ltd 1-ethyl-6-fluoro-1,4-dihydro-4-oxo-7-(1-piperazinyl)-1,8- naphthyridine-3-carboxylic acid-3/2 hydrate and its preparation

Also Published As

Publication number Publication date
CS254958B2 (en) 1988-02-15
FI71144B (fi) 1986-08-14
US4442101A (en) 1984-04-10
ES509538A0 (es) 1983-08-01
AU547082B2 (en) 1985-10-03
JPS57134482A (en) 1982-08-19
PL235049A1 (fi) 1982-09-27
CS99882A2 (en) 1987-07-16
YU43785B (en) 1989-12-31
AU8017382A (en) 1982-08-19
EP0058614B1 (en) 1985-09-18
EP0058614A1 (en) 1982-08-25
PH18177A (en) 1985-04-12
DK160046B (da) 1991-01-21
MX158194A (es) 1989-01-16
DK63482A (da) 1982-08-14
NO156721C (no) 1987-11-11
YU26582A (en) 1986-04-30
JPH0243753B2 (fi) 1990-10-01
KR830009096A (ko) 1983-12-17
NO820430L (no) 1982-08-16
FI71144C (fi) 1986-11-24
NO156721B (no) 1987-08-03
CA1216292A (en) 1987-01-06
PL137259B1 (en) 1986-05-31
HU186473B (en) 1985-08-28
ES8307793A1 (es) 1983-08-01
ZA82740B (en) 1982-12-29
DE3266261D1 (en) 1985-10-24
DK160046C (da) 1991-06-10
KR870000322B1 (ko) 1987-02-27
DD202573A5 (de) 1983-09-21

Similar Documents

Publication Publication Date Title
FI822824A0 (fi) Foerbraenningskammare och foerfarande foer producering av upphettad vaetska
FI822205A0 (fi) Alkanonsyraderivat och foerfarande foer framstaellning av desamma
FI822957A0 (fi) Foerfarande foer indikering och anordning foer genomfoerande av foerfarandet
FI811830A0 (fi) Foerfarande och anordning foer saogning av traevirke
FI811916L (fi) Foerfarande och anordning foer identifiering av rulle
FI813944L (fi) Foerfarande och anordning foer sortering av arkbanor
FI823370L (fi) Behaollare och aemne foer framstaellning av densamma
FI820704L (fi) Foerfarande och elektrokatalyt foer framstaellning av klordioxid
FI820466L (fi) Nytt seskvihydrat av naftyridinderivat och foerfarande foer des framstaellning
FI822308A0 (fi) Foerfarande och anordning foer rengoering av elektroder
FI821018L (fi) Tillsatsaemne och foerfarande foer foerbaettring av effektiviteten foer foderutbytet foer idisslande djur
FI813071L (fi) Foerfaringssaett och anordning foer foerbaettrande av prestationsfoermaogan och verkningsgradet hosfoerbraenningsmotor
FI813133L (fi) Tillslutningsbandprodukt och foerfarande foer tillverkning av densamma
FI811893L (fi) Foerfarande och anordning foer dosering av saogvirke
FI810979L (fi) Ensileringsmedelkomposition foer ensilering av groenfoder och liknande
FI821455A0 (fi) Foerfarande och anordning foer sortering av kornmaterial
FI823797L (fi) Katjonbytarmembraner foer elektrolyscell och foerfaranden foer framstaellning och reparering av desamma
FI823332L (fi) Foerfarande foer alstrande av akustiska svaengningar och en akustisk svaengningskaella foer genomfoav foerfarandet
FI822396A0 (fi) Aemne foer tillverkning av en behaollare och behaollare tillverkad av aemnet
FI820193L (fi) Pappersmaskinsnaolfilt och foerfarande foer framstaellning av densamma
FI810185L (fi) Foerfarande foer utnyttjande av fattiga oxidiska och jaernhaltiga komplexmalmer eller -koncentrat
FI811498L (fi) Foerfarande och anlaeggning foer kapning av saogvaror
FI820200L (fi) Foerfarande foer framstaellning av en antikropp producerande hybridceller och av antikroppar hybridceller och antikroppar
FI824031A0 (fi) Isolering och foerfarande foer faestande av densamma
FI820956L (fi) Foerfarande foer tillvaratagande av cellulas och anlaeggning foer genomfoerande av foerfarandet

Legal Events

Date Code Title Description
MA Patent expired

Owner name: DAINIPPON PHARMACEUTICAL CO.,_LTD.